Who
Eugene A. Woods
Director
Company insider
Files Form 4 as: Director, Johnson & Johnson; Director, Best Buy Co.
In numbers
- Trades disclosed
- 26
- Buys
- 1
- Sells
- 0
- Bought
- $15K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 24 Jan 2019
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K135.717 at $276.31 | filing |
| 8 Sep 2026filed 10 Sep 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K135.72 at $276.31 | filing |
| 9 Jun 2026filed 11 Jun 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K161.089 at $232.79 | filing |
| 9 Jun 2026filed 11 Jun 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K161.09 at $232.79 | filing |
| 23 Apr 2026filed 27 Apr 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —975 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —975 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K154.869 at $242.14 | filing |
| 10 Mar 2026filed 12 Mar 2026 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K154.87 at $242.14 | filing |
| 9 Dec 2025filed 11 Dec 2025 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K185.53 at $202.12 | filing |
| 9 Sep 2025filed 11 Sep 2025 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K210.59 at $178.07 | filing |
| 10 Jun 2025filed 12 Jun 2025 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $36K231.32 at $155.23 | filing |
| 24 Apr 2025filed 28 Apr 2025 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,316 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K188.14 at $166.10 | filing |
| 10 Dec 2024filed 12 Dec 2024 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K208.79 at $149.67 | filing |
| 10 Sep 2024filed 12 Sep 2024 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K188.32 at $165.94 | filing |
| 4 Jun 2024filed 6 Jun 2024 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $31K211.36 at $147.85 | filing |
| 30 Apr 2024filed 28 Feb 2025 | JNJ Johnson & JohnsonPharmaceuticals | SEC FORM 4 Bought | $15K100 at $145.53 | filing |
| 25 Apr 2024filed 29 Apr 2024 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,385.7 at $0.00 | filing |
| 5 Mar 2024filed 7 Mar 2024 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $79K491.45 at $159.80 | filing |
| 5 Mar 2024filed 7 Mar 2024 | JNJ Johnson & Johnsonoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $42K261.99 at $159.80 | filing |
News
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19JNJ · equitybulls.com · 18 Oct 2026Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy.JNJ · fool.com · 17 Oct 2026Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and moreJNJ · seekingalpha.com · 16 Oct 2026
0 headlines in the last 90 days name Eugene A. Woods; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.